COVID-19 (Coronavirus) Update

As the level of COVID-19 infections begins to stabilize in our community, we are starting to reschedule appointments, surgeries, and procedures that were delayed during the pandemic. Learn more about how Duke Health is committed to keeping you safe. Visitor restrictions remain in effect. 

ORCHID - Clinical Trial

What is the Purpose of this Study?

We are doing this study to learn more about the study drug, Hydroxychloroquine, and to determine if it is helpful in treating people with COVID-19.
What is the Condition Being Studied?
COVID-19

Who Can Participate in the Study?

Adults currently in the hospital with a diagnosis of COVID-19.

Age Group
Adults

What is Involved?

If you choose to join this study you will:
-Be randomized (like flipping a coin) to Group 1 or Group 2
--Group 1 will take the study drug (Hydroxychloroquine) for 5 days
--Group 2 will take a placebo (harmless sugar pill) for 5 days
-Have an electrocardiogram (EKG)
-Allow the study team to access your medical information regarding COVID-19
-Complete follow-up phone calls at several time points after you leave the hospital (up to one year).

Study Details

Full Title
Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease
Principal Investigator
Emergency Medicine Specialist
Protocol Number
IRB: PRO00105414
NCT: NCT04332991
Phase
Phase N/A
ClinicalTrials.gov
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698